Zenith Goldline nizatidine
Executive Summary
Final judgement in patent litigation over Lilly's Axid could occur by Oct. 12, Zenith expects, more than 180 days prior to expiration of the '547 patent. The trial is scheduled to begin Sept. 10 and the parties estimate the trial will take five days. "The Pink Sheet" suggested a decision in the trial could come closer to the expiration of the patent. The judge has stayed approval of Zenith's generic through final judgement (1"The Pink Sheet" March 26, p. 10)